HOWTEK INC
10-Q, 1999-11-12
COMPUTER PERIPHERAL EQUIPMENT, NEC
Previous: SYNTHETECH INC, 10-Q, 1999-11-12
Next: DAVIDSON DIVERSIFIED REAL ESTATE II LIMITED PARTNERSHIP, 10QSB, 1999-11-12




                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                    FORM 10-Q

(Mark One)

(X)  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

For the quarterly period ended September 30, 1999

                                       OR

(_)  TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR  15(d)  OF THE  SECURITIES
     EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission file number 1-9341

                                  HOWTEK, INC.
             (Exact name of registrant as specified in its charter)

                Delaware                               02-0377419
     (State or other jurisdiction           (I.R.S. Employer Identification No.)
   of incorporation or organization)

 21 Park Avenue, Hudson, New Hampshire                    03051
(Address of principal executive offices)                (Zip Code)

                                 (603) 882-5200
              (Registrant's telephone number, including area code)

                                 Not Applicable
              (Former name, former address and former fiscal year,
                         if changed since last report)

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirement for the past 90 days. YES __X__ NO _____.

     As of the close of  business  on  November  8, 1999 there  were  13,019,296
shares outstanding of the issuer's Common Stock, $.01 par value.

<PAGE>


                                  HOWTEK, INC.

                                      INDEX

                                                                           PAGE
PART I   FINANCIAL INFORMATION

  Item 1 Financial Statements

         Balance Sheets as of September 30, 1999
         (unaudited) and December 31, 1998                                 3

         Statements of Operations for the three
         month periods ended September 30, 1999 and
         1998 (unaudited) and for the nine month
         periods ended September 30, 1999 and 1998
         (unaudited)                                                       4

         Statement of Changes in Stockholders' Equity
         for the nine month period ended September 30, 1999
         (unaudited)                                                       5

         Statements of Cash Flows for the nine month periods
         ended September 30, 1999 and 1998 (unaudited)                     6

         Notes to Financial Statements (unaudited)                         7


  Item 2 Management's Discussion and Analysis of
         Financial Condition and Results of Operations                     8-13

  Item 3 Quantitative and Qualitative Disclosures about Market Risk        13


PART II  OTHER INFORMATION

  Item 2 Changes in Securities                                             13

  Item 4 Submission of Matters to a Vote of Security Holders               13-14

  Item 5 Other Information                                                 14

  Item 6 Exhibits and Reports on Form 8-K                                  15

Signatures                                                                 16


                                       2

<PAGE>


                                  HOWTEK, INC.

                                 Balance Sheets

<TABLE>
<CAPTION>
                                                       September 30, 1999  December 31, 1998
                                                       ------------------  -----------------
                        Assets                             (unaudited)
<S>                                                       <C>                <C>
Current assets:
  Cash and equivalents                                    $    225,989       $    182,724
  Accounts receivable:
    Trade-net of allowance for doubtful accounts
     of $88,000 in 1999 and $118,000 in 1998                 1,936,925          1,570,081
  Inventory                                                  2,747,417          2,927,082
  Prepaid and other                                             76,618            118,689
                                                          ------------       ------------
      Total current assets                                   4,986,949          4,798,576
                                                          ------------       ------------

Property and equipment:
  Equipment                                                  2,677,777          2,534,635
  Leasehold improvements                                        33,321             27,765
  Motor vehicles                                                 6,050              6,050
                                                          ------------       ------------
                                                             2,717,148          2,568,450
  Less accumulated depreciation and amortization             2,028,028          1,717,445
                                                          ------------       ------------
      Net property and equipment                               689,120            851,005
                                                          ------------       ------------

Other assets:
  Software development costs, net                              488,762            626,577
  Debt issuance costs, net                                      42,413             57,682
  Patents, net                                                  13,971             17,581
                                                          ------------       ------------
      Total other assets                                       545,146            701,840
                                                          ------------       ------------

      Total assets                                        $  6,221,215       $  6,351,421
                                                          ============       ============

         Liabilities and Stockholders' Equity

Current liabilities:
  Accounts payable                                        $  1,413,439       $  1,086,775
  Accrued interest                                             162,471             37,641
  Accrued vacation pay                                          85,821             84,875
  Accrued expenses                                             197,252            224,704
  Loan payable to related parties                              700,000            765,000
                                                          ------------       ------------
      Total current liabilities                              2,558,983          2,198,995

Loan payable to related parties                                590,000               --
Loan payable to unrelated parties                              660,000               --
Convertible subordinated debentures                            117,000          1,881,000
                                                          ------------       ------------
      Total liabilities                                      3,925,983          4,079,995
                                                          ------------       ------------

Commitments and contingencies

Stockholders' equity:
  Common stock, $ .01 par value:  authorized
    25,000,000 shares; issued 13,087,172 in 1999
    and 11,128,082 shares in 1998; outstanding
    13,019,296 in 1999 and 11,060,206 shares in 1998           130,871            111,281
  Additional paid-in capital                                51,543,551         47,938,799
  Accumulated deficit                                      (48,428,926)       (44,828,390)
  Treasury stock at cost (67,876 shares)                      (950,264)          (950,264)
                                                          ------------       ------------
      Stockholders' equity                                   2,295,232          2,271,426
                                                          ------------       ------------

      Total liabilities and stockholders' equity          $  6,221,215       $  6,351,421
                                                          ============       ============
</TABLE>

See accompanying notes to financial statements.


                                       3

<PAGE>


                                  HOWTEK, INC.

                            Statements of Operations

<TABLE>
<CAPTION>
                                                     Three Months                         Nine Months
                                                     September 30,                       September 30,
                                            -------------------------------       -------------------------------
                                                1999              1998               1999               1998
                                             (unaudited)       (unaudited)        (unaudited)        (unaudited)
<S>                                         <C>                <C>                <C>                <C>
Sales                                       $  1,614,930       $  1,231,519       $  5,078,671       $  3,357,401
Cost of Sales                                  1,176,456            929,690          3,897,695          2,823,522
                                            ------------       ------------       ------------       ------------
Gross Margin                                     438,474            301,829          1,180,976            533,879
                                            ------------       ------------       ------------       ------------
Operating expenses:
  Engineering and product development            205,127            299,442            632,726            808,807
  General and administrative                     293,066            316,279          1,059,610          1,005,897
  Marketing and sales                            460,735            450,496          1,322,037          1,251,652
                                            ------------       ------------       ------------       ------------
      Total operating expenses                   958,928          1,066,217          3,014,373          3,066,356

                                            ------------       ------------       ------------       ------------
Loss from operations                            (520,454)          (764,388)        (1,833,397)        (2,532,477)

Interest expense - net                            38,926             47,169          1,767,139            151,178
                                            ------------       ------------       ------------       ------------

Net loss                                    $   (559,380)      $   (811,557)      $ (3,600,536)      $ (2,683,655)
                                            ============       ============       ============       ============

Net loss per share
     Basic and diluted                      $      (0.04)      $      (0.08)      $      (0.29)      $      (0.27)

Weighted average number of shares used
  in computing earnings per share
     Basic and diluted                        12,923,644         10,760,206         12,473,746          9,933,466
</TABLE>

See accompanying notes to financial statements.


                                       4

<PAGE>


                                  HOWTEK, INC.

                  Statement of Changes in Stockholders' Equity

<TABLE>
<CAPTION>
                                                  Common Stock
                                         ----------------------------    Additional
                                           Number of                      Paid-in      Accumulated      Treasury       Stockholders'
                                         Shares Issued     Par Value      Capital        Deficit          Stock           Equity
                                         -------------   ------------   ------------   ------------    ------------    -------------

<S>                                         <C>          <C>            <C>            <C>             <C>             <C>
Balance at December 31, 1998                11,128,082   $    111,281   $ 47,938,799   $(44,828,390)   $   (950,264)   $  2,271,426

Issuance of common stock relative
  to conversion of Convertible
  Subordinated Debentures                    1,764,000         17,639      3,417,519                                      3,435,158

Issuance of common stock
  for payment of debt                          195,090          1,951        187,233                                        189,184

Net loss                                          --             --             --       (3,600,536)           --        (3,600,536)
                                          ------------   ------------   ------------   ------------    ------------    ------------

Balance at September 30, 1999               13,087,172   $    130,871   $ 51,543,551   $(48,428,926)   $   (950,264)   $  2,295,232
                                          ============   ============   ============   ============    ============    ============
</TABLE>

See accompanying notes to financial statements.


                                       5

<PAGE>


                                  HOWTEK, INC.

                            Statements of Cash Flows

<TABLE>
<CAPTION>
                                                          Nine Months        Nine Months
                                                      September 30, 1999  September 30, 1998
                                                      ------------------  ------------------
                                                         (unaudited)         (unaudited)
<S>                                                      <C>                 <C>
Cash flows from operating activities:
  Net income (loss)                                      $(3,600,537)        $(2,683,655)
                                                         -----------         -----------
  Adjustments  to reconcile  net income
  (loss) to net cash provided by
  operating activities:
  Depreciation                                               310,583             331,691
  Amortization                                               225,880             165,873
  Interest relative to conversion of Convertible           1,671,158                --
 (Increase) decrease:
    Accounts receivable                                     (366,844)            346,969
    Inventory                                                179,665             307,337
    Other current assets                                      42,071             (28,168)
  Increase (decrease):
    Accounts payable                                         326,664            (256,224)
    Accrued expenses                                          98,324             165,526
                                                         -----------         -----------
      Total adjustments                                    2,487,501           1,033,004
                                                         -----------         -----------

      Net cash provided by (used for)
       operating activities                               (1,113,036)         (1,650,651)
                                                         -----------         -----------

Cash flows from investing activities:
  Patents, software development and other                    (69,186)           (157,875)
  Additions to property and equipment                       (148,697)           (206,280)
                                                         -----------         -----------
      Net cash used for investing activities                (217,883)           (364,155)
                                                         -----------         -----------

Cash flows from financing activities:
  Issuance of common stock for cash                          189,184           1,709,466
  Proceeds of loan from related parties                      525,000             300,000
  Proceeds of loan from unrelated parties                    660,000                --
                                                         -----------         -----------
      Net cash provided by financing activities            1,374,184           2,009,466
                                                         -----------         -----------

    Increase (decrease) in cash and equivalents               43,265              (5,340)
    Cash and equivalents, beginning of period                182,724             235,326
                                                         -----------         -----------
    Cash and equivalents, end of period                  $   225,989         $   229,986
                                                         ===========         ===========

Supplemental disclosure of cash flow information:
  Interest paid                                          $     5,265         $   107,611
                                                         ===========         ===========
</TABLE>

See accompanying notes to financial statements.


                                       6

<PAGE>


                                  HOWTEK, INC.

                          Notes to Financial Statements

                               September 30, 1999


(1)  Accounting Policies

     In the opinion of management all adjustments and accruals  (consisting only
     of  normal   recurring   adjustments)   which  are  necessary  for  a  fair
     presentation  of  operating  results  are  reflected  in  the  accompanying
     financial  statements.  Reference  should be made to Howtek,  Inc.'s Annual
     Report on Form 10-K for the year ended  December  31, 1998 for a summary of
     significant accounting policies. Interim period amounts are not necessarily
     indicative of the results of operations for the full fiscal year.

(2)  Loan Payable to Related Party

     The  Company  has a  Convertible  Revolving  Credit  Promissory  Note ("the
     Convertible  Note") and Revolving  Loan and Security  Agreement  (the "Loan
     Agreement")  with Mr. Robert Howard,  Chairman of the Board of Directors of
     the  Company,  under which Mr.  Howard has agreed to advance  funds,  or to
     provide  guarantees  of advances  made by third  parties in an amount up to
     $3,000,000. Outstanding advances are collateralized by substantially all of
     the assets of the Company and bear interest at prime interest rate plus 2%.
     The Convertible  Note entitles Mr. Howard to convert  outstanding  advances
     into  shares  of the  Company's  common  stock  at any  time  based  on the
     outstanding  closing market price of the Company's common stock at the time
     each advance is made.

     As of September 30, 1999, the Company had  $2,750,000  available for future
     borrowings under the Loan Agreement.

     In the third quarter of 1998, the Company  borrowed,  (i) $565,000 from Mr.
     Robert Howard, the Company's Chairman,  and (ii) $200,000 from Dr. Lawrence
     Howard, the son of Mr. Robert Howard,  pursuant to Secured Demand Notes and
     Security  Agreements  (the  "Notes").  Principal  on the  Notes are due and
     payable in full,  together with interest accrued and any penalties provided
     for,  on  demand.  Under the terms of the Notes the  Company  agreed to pay
     interest at the lower rate of (a) 12% per annum,  compounded monthly or (b)
     the maximum rate  permitted by  applicable  law. The Notes  currently  bear
     interest at 12%. Payment of the Notes is secured by a security  interest in
     certain assets of the Company. In February 1999, the Company repaid $65,000
     to Mr.  Robert  Howard.  As of  September  30,  1999,  the Company owed (i)
     $500,000 to Mr. Robert Howard, and (ii) $200,000 to Dr. Lawrence Howard.


                                       7

<PAGE>


Item 2. Management's  Discussion and Analysis of Financial Condition and Results
of Operations

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995:

Certain  information  included in this Item 2. and  elsewhere  in this Form 10-Q
that are not historical facts contain forward looking  statements that involve a
number of known and unknown  risks,  uncertainties  and other factors that could
cause the actual  results,  performance  or  achievements  of the  Company to be
materially  different  from  any  future  results,  performance  or  achievement
expressed  or  implied  by such  forward  looking  statements.  These  risks and
uncertainties  include,  but are not limited  to,  uncertainty  of future  sales
levels, protection of patents and other proprietary rights, the impact of supply
and   manufacturing   constraints  or   difficulties,   possible   technological
obsolescence of products,  competition,  the failure of the Company or key third
parties with which the Company does business to achieve year 2000 compliance and
other  risks  detailed  in the  Company's  Securities  and  Exchange  Commission
filings.  The words  "believe",  "expect",  "anticipate"  and "seek" and similar
expressions identify  forward-looking  statements.  Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak only as of
the date the statement was made.

Results of Operations

Overview

     Since beginning a turn-around program in early 1998, Howtek has become more
focused on medical product opportunities and has demonstrated consistent year to
year growth in medical  product  sales.  The Company  believes its  MultiRAD(TM)
radiological  film digitizers are distinguished in markets for computer assisted
mammography,   teleradiology  and  medical  image  archiving  on  the  basis  of
proprietary,   solid  state  "Red  LED"  illumination  systems,  elimination  of
fluorescent  tubes,  superior  image quality and value.  The  Company's  medical
business operates at higher gross margins than Howtek's traditional graphic arts
business.  Further, because the Company works primarily with systems integrators
in the sale of Howtek medical film  digitizers,  operating costs associated with
support of the medical product  business are lower than comparable  costs in the
Company's traditional graphic arts segment. For these reasons, increased medical
sales are  expected to be a  continuing  and  increasingly  important  factor in
Howtek's plan to improve its overall financial performance.

     Howtek  has now  completed  updating  all key  graphic  arts  hardware  and
software  product  lines.  The Company  introduced its new  HiResolveTM  line of
exceptionally  high-resolution  drum scanners during the fourth quarter of 1998.
During the first quarter of 1999,  Howtek  secured rights to market and sell the
award  winning  Scanview  flatbed  scanner line in the United States and Canada,
with the first sales of Scanview products occurring at the end of March 1999. In
February  1999,  Howtek  introduced  the  Digital  PhotoLabTM  software  system,
acquired on an  exclusive  basis from a third  party.  Digital  PhotoLab is used
together  with  Howtek drum  scanners  to meet the needs of photo  professionals
using  negative   original   images,   producing   final  images  on  high-speed
photographic paper, and printing on a new generation of wide format color inkjet
printers.


                                       8

<PAGE>


     An additional  element in the  Company's  improved  performance  has been a
rethinking  and a  restructuring  of the way Howtek  operates,  to achieve  more
productivity while reducing costs. In manufacturing,  the Company is now working
with  a  series  of   high-value   manufacturing   resources  to  outsource  key
manufacturing tasks and components. This process is substantially complete. This
outsourcing  has  permitted  a  substantial  reduction  in direct  and  indirect
manufacturing  costs and expenses.  In other  operating  areas,  the Company has
achieved overall expense  reductions while increasing sales and while increasing
its investments in marketing and sales activities.

Quarter Ended  September  30, 1999 compared to Quarter Ended  September 30, 1998
and Nine Months Ended September 30, 1999 compared to Nine Months Ended September
30, 1998

Sales.  Sales for the three months ended September 30, 1999 were $1,614,930,  an
increase of $383,411 or 31% from the  comparable  period in 1998.  Sales for the
nine months ended September 30, 1999 were $5,078,671,  an increase of $1,721,270
or 51% from the comparable period in 1998.

The Company continues to emphasize its medical business opportunities.  Sales of
the  Company's  medical  imaging  products  increased  30% from  $336,370 in the
quarter ended September 30, 1998 to $436,237 over the comparable period in 1999,
and  increased  51% from  $761,764 in the nine month period ended  September 30,
1998 to $1,150,360 for the nine month period ended September 30, 1999.  Sales of
the Company's prepress and graphic arts products increased 17%, from $568,455 in
the quarter ended  September 30, 1998 to $665,460 over the comparable  period in
1999, and increased 36% from $1,943,657 in the nine month period ended September
30, 1998 to  $2,644,782  for the nine month  period  ended  September  30, 1999.
Increased  sales  are  due to the  introduction  of its new  HiResolve(TM)  drum
scanner  product during the fourth quarter of 1998, the  introduction of its new
Digital  PhotoLab(TM)  products  in the first  quarter  of 1999,  and  increased
marketing and advertising  investments.  Also, during the first quarter of 1999,
the  Company  completed  its  exclusive  agreement  to market and sell the award
winning Scanview flatbed scanner line in the United States and Canada,  with its
first sales occurring at the end of March 1999.

Gross  Margins.  Gross  margins  for the  three  and nine  month  periods  ended
September  30, 1999  increased to 27% and 23%,  respectively,  from 25% and 16%,
respectively,  in the comparable  periods in 1998.  Gross margins have improved,
and are  expected  to  further  improve  during  1999,  as a result  of  reduced
production  overhead  and  indirect  production  expenses,  associated  with the
Company's  continuing  overhead  and  expense  control  measures  and  with  the
Company's increased outsourcing of production and assembly services.  Production
overhead and indirect  production costs have declined in absolute terms, and are
expected to continue to decline  over the  immediate  future;  at the same time,
sales have increased, decreasing such production costs as a percentage of sales.
Both factors continue to contribute to improved margins.

Engineering and Product  Development.  Engineering and product development costs
for the three month period ended  September 30, 1999 decreased 31% from $299,442
in 1998 to $205,127 in 1999.  Engineering and product  development costs for the
nine month period ended  September 30, 1999  decreased 22% from $808,807 in 1998
to $632,726 in 1999. The decrease results primarily


                                       9

<PAGE>


from reductions in personnel expenses.  The Company expects to continue reducing
costs and overhead  associated  with  engineering  and product  development,  in
absolute terms and as a percentage of sales,  as it increases its utilization of
outside and contract  engineering  resources  as  appropriate.  In general,  the
Company  seeks to shift its  engineering  and  development  priorities,  and the
allocation of its engineering and development resources, to its medical business
opportunities.

General and  Administrative.  General and  administrative  expenses in the three
month period ended  September 30, 1999 decreased  slightly from $316,279 in 1998
to  $293,066  in 1999.  General  and  administrative  expenses in the nine month
period ended  September 30, 1999 increased due to the $186,662  returns  reserve
established  in the first  quarter  of 1999 to permit  the  Company to take back
discontinued  HiDemand 400 graphic arts scanner products to encourage  resellers
and  customers  to  acquire  new  Scanview  products,   especially  in  reseller
demonstration  locations, and a non-recurring expense of $21,142 associated with
the  write off of  tooling  and  inventories  associated  with the  discontinued
HiDemand 400 product.  Prior to accounting for this reserve, and write down, the
general and  administrative  expenses for the nine month period ended  September
30,  1999,  decreased  15% from  $1,005,897  in 1998 to $851,806  in 1999.  This
decrease is due primarily to reductions in personnel expenses.  Giving effect to
the  HiDemand  400 reserve  and write  downs,  the  general  and  administrative
expenses for the nine month period ended  September 30, 1999 were  $1,059,610 in
1999. The Company expects general and administrative  expenses to decline during
the  balance  of 1999 as  compared  to 1998,  as a  percentage  of sales  and in
absolute terms.

Marketing and Sales  Expenses.  Marketing and sales  expenses in the three month
period ended  September  30, 1999  increased  slightly  from $450,496 in 1998 to
$460,735 in 1999.  Marketing  and sales  expense in the nine month  period ended
September 30, 1999  increased 6% from  $1,251,652 in 1998 to $1,322,037 in 1999.
The increase  results  primarily from increases in advertising,  promotional and
trade  show  expenses.  Commissions  payable  to  inside  sales  representatives
increased  as a result  of  increased  sales.  Effective  in April of 1999,  the
Company changed its sales compensation  structure to provide compensation on the
basis of gross margins, rather than net sales. The Company expects marketing and
sales  expenses  to  increase  in 1999 as  compared  to  1998,  while  remaining
relatively constant as a percentage of sales.

Interest  Expense.  Net interest expense of $1,767,139 for the nine month period
ended September 30, 1999 includes interest expense of $1,671,158 relative to the
conversion of  Convertible  Subordinated  Debentures as required by Statement of
Financial  Accounting  Standards No. 84,  "Induced  Conversions  of  Convertible
Debt".  This charge is wholly offset by a corresponding  accounting  increase to
additional paid-in capital by $1,671,158.  The charge and corresponding  benefit
relate  to the  conversion  to  equity  during  the  first  quarter  of  1999 of
$1,764,000 of the Company's previously  outstanding 9% Convertible  Subordinated
Debentures,  due 2001  (the "9%  Debenture").  In  December  1998,  the  Company
provided for a temporary  reduction in the conversion  price of the 9% Debenture
to  encourage  conversion  to common  stock,  and thereby  reduce cash  interest
expenses,  and sinking  fund  payments  associated  with the 9%  Debenture.  See
"Liquidity and Capital Resources".


                                       10

<PAGE>


As a result of the  foregoing,  the  Company  recorded a net loss of $559,380 or
$0.04 per share for the quarter ended  September 30, 1999 on sales of $1,614,930
compared  to a net loss of  $811,557  or $0.08 per share for the same  period in
1998 on sales of $1,231,519.


Liquidity and Capital Resources

The Company's ability to generate cash adequate to meet its requirements depends
primarily on operating  cash flow and the  availability  of a $3,000,000  credit
line under a Convertible Note and Revolving Loan and Security Agreement with its
Chairman, of which $2,750,000 was available at September 30, 1999.

At  September  30, 1999 the Company had current  assets of  $4,986,949,  current
liabilities  of  $2,558,983  and  working  capital of  $2,427,966.  The ratio of
current assets to current liabilities was 2:1

In the third quarter of 1998, the Company borrowed, (i) $565,000 from Mr. Robert
Howard, the Company's Chairman,  and (ii) $200,000 from Dr. Lawrence Howard, the
son of Mr.  Robert  Howard,  pursuant  to  Secured  Demand  Notes  and  Security
Agreements (The "Notes").  Principal on these Notes are due and payable in full,
together with interest accrued and any penalties provided for, on demand.  Under
the terms of the Notes the Company  agreed to pay  interest at the lower rate of
(a) 12% per annum,  compounded  monthly or (b) the  maximum  rate  permitted  by
applicable law. The Notes  currently bear interest at 12%.  Payment of the Notes
is secured by a security interest in certain assets of the Company.

In February  1999,  the  Company  repaid  $65,000 to Mr.  Robert  Howard.  As of
September 30, 1999, the Company owed (i) $500,000 to Mr. Robert Howard, and (ii)
$200,000 to Dr. Lawrence Howard. The Company believes it can adequately fund its
working capital and capital  equipment  requirements  based upon its anticipated
level of sales for 1999 and the line of  credit  available  under the  Revolving
Loan Agreement with its Chairman.

As of December 31, 1998, the Company's outstanding balance on its $8,000,000, 9%
Convertible Subordinated Debentures (the "Debentures"), which come due 2001, was
$1,881,000.  The Debentures were convertible into common stock of the Company at
the  conversion  price of $19.00 per share,  subject  to  adjustment  in certain
events.  On December  31,  1998,  the Company and the Trustee of the  Debentures
entered into a Second Supplemental  Indenture (the "Agreement").  The purpose of
the Agreement was to reduce the conversion  price for the Debentures from $19.00
per  share to  $1.00  per  share,  subject  to  adjustment  as set  forth in the
Indenture,  during the period from  December  31, 1998  through  March 23, 1999.
Under the Agreement, Debentures owned by related parties in the principal amount
of  $300,000  were  converted  into  300,000  shares  of  Common  Stock,  at the
conversion  price of $1.00 per share on December 31, 1998.  Interest expense and
corresponding  credit to  additional  paid-in  capital of $284,211 were recorded
relative to the conversion of Convertible Subordinated Debentures as required in
terms of Statement of Financial  Accounting  Standards  No. 84,  ("SFAS No. 84")
"Induced Conversions of Convertible Debt".


                                       11
<PAGE>

During the period from January 1, 1999 through March 23, 1999  Debentures in the
principal  amount of $1,764,000  were converted into 1,764,000  shares of Common
Stock,  at the  conversion  price of  $1.00  per  share.  Interest  expense  and
corresponding  credit to additional  paid-in  capital of $1,671,158 was recorded
relative to the conversion of Convertible Subordinated Debentures as required in
terms of SFAS No. 84. As of  September  30, 1999 there was $117,000 in principal
amount of Debentures outstanding.

During the first nine months of 1999,  the Company  borrowed,  (i) $660,000 from
unrelated parties, (ii) $30,000 from Mr. W. Scott Parr, the Company's President,
Chief  Executive  Officer,  and  (iii)  $310,000  from Mr.  Robert  Howard,  the
Company's  Chairman,  pursuant to Convertible  Promissory Notes (the "Promissory
Notes"). Principal on these Promissory Notes are payable in equal payments based
on the  borrowed  amount at the end of each  quarter  starting  March  31,  2003
through  December 31, 2006.  Under the terms of the Promissory Notes the Company
agreed to pay  interest at a fixed rate of 7% per annum,  beginning  on December
31, 1999 and each  succeeding  year during the terms  hereof.  At the  Company's
option it may pay the  interest  in either cash or in  restricted  shares of the
Company's common stock, or in any combination  thereof.  Interest paid in shares
of the Company's  common stock will be paid at the greater of $1.00 per share or
the average per share closing market price at the time each interest  payment is
due. The Promissory  Notes entitle the payees to convert  outstanding  principal
due into shares of the Company's common stock at $1.00 per share.


Subsequent Events

In October  1999,  the Company  borrowed an  additional  $80,000 from Mr. Robert
Howard under the Convertible Note and Revolving Loan and Security Agreement,  of
which $2,670,000 was available at October 31, 1999.


Impact of the Year 2000

Many currently installed computer systems and software programs were designed to
use only a two-digit date field. These date code fields will need to accept four
digit entries to distinguish  21st century dates from 20th century dates.  Until
the date  fields  are  updated,  the  systems  and  programs  could fail or give
erroneous  results when  referencing  dates  following  December 31, 1999.  Such
failure or errors  could  occur  prior to the  actual  change in  century.  This
potential problem is referred to as the "Year 2000" or "Y2K" issue.

In 1998,  the  Company  established  a review  program to address  the Year 2000
issue. The effort encompasses hardware,  software, networks, personal computers,
manufacturing  and other  facilities,  and  suppliers.  The Company is currently
assessing  alternative  manufacturing  and implementing a new financial  control
system which is Y2K compliant,  and expects  implementation to be complete prior
to the end of December,  1999. The Company's  products are not date aware and do
not present a Year 2000 problem to its customers.



                                       12
<PAGE>

The  failure  to  correct  a  material  Year  2000  problem  could  result in an
interruption  in,  or a  failure  of,  certain  normal  business  activities  or
operations.  Such failures could  materially and adversely  affect the Company's
results of  operations,  liquidity and financial  condition.  Due to the general
uncertainty  inherent  in the Year  2000  problem,  resulting  in part  from the
uncertainty of the Year 2000 readiness of third-party suppliers,  the Company is
unable to  determine  at this time  whether  the  consequences  of the Year 2000
failures  will have a material  impact on the Company's  results of  operations,
liquidity or financial condition.

Costs  related to the Year 2000 issue are  expensed as  incurred  and are funded
through   operating  cash  flows.   The  total  cost  associated  with  required
modifications  to become Year 2000  compliant  is not expected to be material to
the Company's  financial  position.  The  estimated  total cost of the Year 2000
program is now approximately $20,000. The Company expensed approximately $10,000
related to the cost of upgrading  non-compliant hardware and software.  Time and
cost  estimates  are  based on  currently  available  information  and  could be
affected by the ability to correct all relevant  computer  codes and  equipment.
The Company has not  developed  a  contingency  plan in the event that it or its
third party suppliers experience Y2K difficulties.


Item 3.   Quantitative and Qualitative Disclosures about Market Risk

          Not applicable.




PART II  OTHER INFORMATION


Item 2.  Changes in Securities

     During the third quarter of 1999, the Company  entered into an agreement to
borrow an additional  $60,000  pursuant to Promissory  Notes. See "Liquidity and
Capital Resources". These notes were issued in a private offering pursuant to an
exemption  from  registration  under Section 4(2) of the  Securities Act of 1933
and; or Regulation D thereunder.


Item 4.   Submission of Matters to a Vote of Security Holders.

On September 28, 1999,  the Company held an Annual  Meeting of  Stockholders  at
which (i) the election of directors,  (ii) amendment of the Company's 1993 Stock
Option  Plan to  increase  the number of shares of the  Company's  common  stock
issuable  thereunder  from 1,000,000 to 1,625,000  shares and (iii)  authorize a
class  of  1,000,000   shares  of  preferred  stock  were  voted  on  by  common
stockholders of the Company. The results of the vote were as follows:


                                       13
<PAGE>

i.   Election of Directors

     Robert Howard,  W. Scott Parr, Ivan Gati,  Sheila  Horwitz,  Kit Howard and
Harvey  Teich  were  elected  to  serve as  members  of the  Company's  Board of
Directors for the ensuing year and until the election and qualification of their
successors.

The votes cast by stockholders with respect to the election of Directors were as
follows:

                                                                  Number of
Names of Nominees              Number of Votes For                Votes Withheld
- -----------------              -------------------                --------------

Robert Howard                  11,653,328                         344,905
W. Scott Parr                  11,656,503                         341,730
Ivan Gati                      11,652,003                         346,230
Sheila Horwitz                 11,655,403                         342,830
Kit Howard                     11,651,803                         346,430
Harvey Teich                   11,651,753                         346,480


ii.  Amendment to 1993 Stock Option Plan

Votes                      Votes Cast                   Votes          Broker
Cast For                     Against                 Abstaining      Non-Votes
- --------                     -------                 ----------      ---------

10,506,190                   532,485                   79,935         879,623


iii. Amendment to Certificate of Incorporation to Authorize Preferred Stock

Votes                      Votes Cast                   Votes          Broker
Cast For                    Against                  Abstaining      Non-Votes
- --------                    -------                  ----------      ---------

6,420,196                   690,320                    68,085        4,819,632


Item 5.   Other Information

     During the second  quarter  1999,  the bid price for the  Company's  common
stock had fallen below the $1 bid level  required for  continued  trading of the
Company's  common  stock on the Nasdaq  Small Cap Market.  In October,  1999 the
Company had been  notified by Nasdaq  that its listing was being  reviewed.  The
Company  has been  notified  by Nasdaq  that the  required  bid levels have been
achieved  and the  Company's  common  stock will  continued  to be traded on the
Nasdaq Market.



                                       14
<PAGE>

Item 6.   Exhibits and Reports on Form 8-K

          (a)  Exhibits

          27   Financial Data Schedule

          (b)  No reports on Form 8-K were filed  during the  quarter  for which
               this report is filed.


                                       15
<PAGE>

                                   Signatures



Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly  caused  this  report  to be signed  on its  behalf by the  undersigned
thereunto duly authorized.


                                                         Howtek, Inc.
                                                          (Company)



Date:    November 12, 1999                  By:    /s/ W. Scott Parr
     ---------------------------------          --------------------------------
                                                   W. Scott Parr
                                                   President, Chief Executive
                                                   Officer, Director


Date:    November 12, 1999                  By:   /s/ Annette L. Heroux
     ---------------------------------          --------------------------------
                                                   Annette L. Heroux
                                                   Vice President Finance,
                                                   Chief Financial Officer




                                       16

<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial  information extracted from Form 10Q at
September  30,  1999 and is  qualified  in its  entirety  by  reference  to such
financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                                DEC-31-1999
<PERIOD-START>                                   JAN-01-1999
<PERIOD-END>                                     SEP-30-1999
<CASH>                                               225,989
<SECURITIES>                                               0
<RECEIVABLES>                                      1,848,925
<ALLOWANCES>                                          88,000
<INVENTORY>                                        2,747,417
<CURRENT-ASSETS>                                   4,986,949
<PP&E>                                             2,717,148
<DEPRECIATION>                                     2,028,028
<TOTAL-ASSETS>                                     6,221,215
<CURRENT-LIABILITIES>                              2,558,983
<BONDS>                                              117,000
                                      0
                                                0
<COMMON>                                             130,871
<OTHER-SE>                                         2,164,361
<TOTAL-LIABILITY-AND-EQUITY>                       6,221,215
<SALES>                                            5,078,671
<TOTAL-REVENUES>                                   5,078,671
<CGS>                                              3,897,695
<TOTAL-COSTS>                                      3,897,695
<OTHER-EXPENSES>                                     632,726
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                 1,767,139
<INCOME-PRETAX>                                   (3,600,536)
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                               (3,600,536)
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                      (3,600,536)
<EPS-BASIC>                                            (0.29)
<EPS-DILUTED>                                          (0.29)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission